Related Experiment Video
Updated: Jul 6, 2026
Dissection of a Mouse Eye for a Whole Mount of the Retinal Pigment Epithelium
Published on: February 27, 2011
DNA Methylation Dynamics in a Mouse Model of Retinitis Pigmentosa
Lu Huang1, Lydia Tai Wai2, Kin-Sang Cho2
1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
Abstract:
Retinitis pigmentosa (RP) is a group of sight-threatening genetic diseases characterized by progressive degeneration of photoreceptors, leading to severe vision loss from childhood to adulthood. With limited treatment options, understanding the molecular mechanisms underlying RP is crucial. Increased DNA methylation, especially in degenerating photoreceptors, is a contributing factor to retinal damage in RP. To exploit the molecular insights into methylation-driven pathways, this study investigated the DNA methylation patterns and their potential roles in photoreceptor degeneration in a mouse model of RP, specifically mice carrying a rhodopsin deficiency (Rho-/-). Elevated levels of DNA methyltransferases (DNMTs) and DNA methylation were observed during photoreceptor degeneration. Importantly, weekly intravitreal injections of the pan DNMT inhibitor decitabine in Rho-/- mice significantly improved photoreceptor morphology and visual function, as evidenced by electroretinogram, spectral-domain optical coherence tomography, and optomotor response-based visual behavior assays. Further histologic and immunohistochemical assessments revealed increased survival of cone photoreceptors and thicker outer nuclear layers in decitabine-treated mice compared with controls. Together, these findings revealed that the dynamics of DNA methylation correlate with photoreceptor degeneration. Inhibition of DNMTs mitigated the morphologic and functional impairments associated with the genetic defects in photoreceptors, suggesting that targeting DNA methylation could be a viable therapeutic strategy for neuroprotection in RP.
Insights
Inhibition of DNA methylation, a key factor in retinal degeneration, improved photoreceptor survival and vision in a mouse model of retinitis pigmentosa (RP). This suggests targeting DNA methylation could be a novel therapeutic strategy for RP.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Retinitis pigmentosa (RP) is a group of inherited retinal diseases causing progressive photoreceptor degeneration and vision loss.
- Increased DNA methylation is implicated in photoreceptor damage in RP, highlighting methylation pathways as potential therapeutic targets.
Purpose of the Study:
- To investigate the role of DNA methylation patterns in photoreceptor degeneration in a mouse model of RP (Rho-/-).
- To evaluate the therapeutic potential of inhibiting DNA methyltransferases (DNMTs) for treating RP.
Main Methods:
- Analysis of DNA methylation patterns and DNMT levels in Rho-/- mice.
- Treatment of Rho-/- mice with decitabine, a pan-DNMT inhibitor, via intravitreal injections.
- Assessment of photoreceptor morphology, survival, and visual function using electroretinography, OCT, and behavioral assays.
Main Results:
- Elevated DNA methylation and DNMT levels were observed during photoreceptor degeneration in Rho-/- mice.
- Decitabine treatment significantly improved photoreceptor morphology and visual function.
- Histologic analysis showed increased cone photoreceptor survival and thicker outer nuclear layers in treated mice.
Conclusions:
- DNA methylation dynamics correlate with photoreceptor degeneration in RP.
- Inhibition of DNMTs mitigates RP-associated impairments, suggesting a viable therapeutic strategy for neuroprotection in RP.
